Daehwa Pharmaceutical Co Ltd

With a few South Korean pharma firms now entering late-stage clinical trials for their Alzheimer's disease drug candidates, and many others actively pursuing development, hopes are brewing that the co

With a few South Korean pharma firms now entering late-stage clinical trials for their Alzheimer's disease drug candidates, and many others actively pursuing development, hopes are brewing that the co

The STAR Market of the Shanghai Stock Exchange, a Nasdaq-style bourse for pre-revenue startup companies, has rejected one biotech’s application for an initial public offering for the first time since